Metformin Guide (2026)
Complete Guide & Evidence (2026)
First-line Type 2 diabetes drug now studied for longevity (TAME trial). Activates AMPK, reduces insulin/IGF-1 signaling, and has anti-cancer properties.
How Metformin Works
Metformin Protocol Overview
Monitor: Annual B12 levels, eGFR, HbA1c. Avoid on days of heavy exercise (controversial) and hold before contrast imaging. Use extended-release to minimize GI side effects.
Metformin Longevity Research Timeline
Metformin first described in France. Used for T2D in Europe from 1958.
NEJM paper: diabetics on metformin outlive matched non-diabetics — landmark longevity signal.
FDA approves TAME (Targeting Aging with Metformin) trial protocol — first FDA-approved aging trial.
TAME trial actively enrolling ~3,000 healthy adults aged 65–79. Results expected 2027.
Vital Protocol FAQs
Guide FAQs
First-line Type 2 diabetes drug now studied for longevity (TAME trial). Activates AMPK, reduces insulin/IGF-1 signaling, and has anti-cancer properties.
Yes. Shotlee supports tracking Metformin doses, side effects, and health metrics. It is free to use.
Track Your Metformin Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
📚References & sources
Latest on Metformin

Semaglutide vs. Tirzepatide: Unpacking New Diabetes Insights & Long COVID Clues
Discover how new studies are reshaping our understanding of Type 2 diabetes management with tirzepatide and offering critical insights into the biological drivers of Long COVID's persistent neurological symptoms.
6 min read
Unexpected Discoveries: How Failed Drugs Became Medical Breakthroughs
Discover how serendipity and keen observation transformed drug development, leading to life-changing treatments for conditions ranging from diabetes and obesity to erectile dysfunction and wrinkles.
6 min read
GLP-1s Don't Work for Everyone: What to Know If Not Seeing Results
Started GLP-1s for weight loss or blood sugar control but seeing no results? New research in Genome Medicine reveals that 10% of people carry PAM gene variants linked to weaker responses. Experts explain genetics, common pitfalls, testing, and effective alternatives to help you succeed.
7 min read